IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis
- 30 January 2021
- journal article
- research article
- Published by Anticancer Research USA Inc. in Anticancer Research
- Vol. 41 (2), 783-794
- https://doi.org/10.21873/anticanres.14830
Abstract
Background/Aim: The inflammatory cytokine IL-8 and its receptor CXCR2 are key signalling pathway molecules in cancer development. We hypothesized that IL-8/CXCR2 signalling promotes tumour progression in oesophageal squamous cell carcinoma (ESCC) patients. Materials and Methods: We examined the relationship between IL-8/CXCR2 expression and clinicopathological factors by immunohistochemistry in samples from 63 patients with resectable ESCC. The effects of IL-8/CXCR2 signalling on cell proliferation and gene expression were examined in vitro and in vivo using ESCC cell lines. Results: Increased IL-8/CXCR2 signalling was associated with shorter overall survival (p<0.05) and recurrence-free survival (p<0.05) in ESCC patients. Multivariate analysis identified IL-8/CXCR2 expression as a prognostic factor for surgically treated ESCC (p<0.05). In vitro, IL-8 exposure or over-expression significantly enhanced ESCC cell proliferation. SB225002, a CXCR2-specific antagonist, and IL-8 siRNA significantly suppressed cell proliferation. Conclusion: IL-8/CXCR2 expression is an independent prognostic factor for surgically treated ESCC, and IL-8/CXCR2 signalling contributes to ESCC cell proliferation.Keywords
This publication has 35 references indexed in Scilit:
- Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinomaSurgery, 2013
- A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)Annals of Surgical Oncology, 2011
- CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasionBritish Journal of Cancer, 2009
- CXC‐chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancerInternational Journal of Cancer, 2009
- Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinomaMolecular Cancer, 2008
- Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinomaBMC Cancer, 2007
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinomaAnnals of Oncology, 2004
- Shutting down Wnt signal-activated cancer.Nature Genetics, 2004
- The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinomaJournal of the American College of Surgeons, 2004